InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,443.60
(
2.15%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
-1.03%
)
Bitcoin
63,000.00
(
6.56%
)
Post# of 125
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

BollixMeArse

Send PM Follow Ignore
Followers 1
Posts 121
Boards Moderated 0
Alias Born 02/28/2013

BollixMeArse

Re: None

Friday, 10/17/2014 8:14:07 AM

Friday, October 17, 2014 8:14:07 AM

Post# of 125
New Positive Clinical Data Supports Quest Towards Orphan Designations

Seeking Alpha Article.

http://seekingalpha.com/article/2569135-new-positive-clinical-data-supports-quest-towards-orphan-designations?uprof=45

Summary

We view the new clinical data as highly promising.
2nd-Gen viral vector showing more controlled delivery and longer duration of effect.

MDGN reveals three orphan targets, two of which could enter clinical trials in 2015.

Highly Promising Trial Data with Next-Gen Vector, Orphan Indications Revealed. Q3 Results
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up